Introduction {#Sec1}
============

Congenital clubfoot, also called talipes equinovarus, is a common and serious birth defect, affecting an estimated one of every 1000 live births.^[@CR1]^ Clubfoot is characterized by structural defects of several tissues of the foot and lower leg, which leads to abnormal positioning of foot and ankle joints.^[@CR2]^ If left untreated, it can become a severe disability and deformity.^[@CR3]^ Approximately 80% of clubfoot cases are isolated birth defects, having an idiopathic aetiology.^[@CR4]^ The remaining 20% of cases are due to associated malformations, chromosomal abnormalities and known genetic syndromes, such as distal arthrogryposis (DA) and myleomeningocele.^[@CR5]^

However, there is strong evidence for a genetic basis for isolated clubfoot. Approximately 25% of all isolated cases report a family history of clubfoot.^[@CR6]^ Data from twin studies shows a higher concordance in monozygotic (33%) than dizygotic (3%) twins,^[@CR4]^ and more recent data estimates heritability of isolated clubfoot at around 30%.^[@CR7]^ Monochorionic triplets all affected with bilateral isolated clubfoot have been observed,^[@CR8]^ further supporting a genetic aetiology for isolated clubfoot. In addition, prevalence of clubfoot varies across ethnic populations, from 0.39 cases per 1000 births in Chinese populations to seven cases per 1000 births in Hawaiians and Maoris.^[@CR9]-[@CR11]^ Further, the ratio of isolated clubfoot among males and females is 2:1, and this ratio is consistent across ethnic groups.^[@CR11],[@CR12]^ Taken together, this data points to an obvious role of genetics in isolated clubfoot. As the clinical presentation between the isolated and syndromic forms can be similar, it is possible that by examining the genes involved in syndromic clubfoot, i.e. those disorders that often have clubfoot as one symptom of many, we may find further clues to the underlying mechanisms of isolated clubfoot.

Genetics of isolated clubfoot {#Sec2}
=============================

PITX1-TBX4 pathway {#Sec2.1}
------------------

Although few causative genes are known, progress has been made on the genetics of isolated clubfoot. The strongest genetic evidence is the *PITX1-TBX4* pathway, the proper function of which is required for normal hindlimb development.^[@CR13],[@CR14]^ Variation in this pathway has been linked to isolated clubfoot phenotypes through a segregating dominant mutation in *PITX1*,^[@CR15]^ inherited *TBX4* microduplications,^[@CR12],[@CR16],[@CR17]^ Pitx1 mouse knockout studies^[@CR18]^ and copy-number variants.^[@CR19]^

Homeobox (HOX) genes {#Sec2.2}
--------------------

In addition to the *PITX1-TBX4* pathway, HOX genes also contain some of the more convincing genetic associations with clubfoot phenotypes. HOX genes comprise four gene clusters (HOXA-D) and these clusters are known to coordinate and mediate limb development. In fact, these genes play critical roles in skeletal patterning throughout the axial and appendicular skeleton.^[@CR20]^ Single nucleotide polymorphism (SNPs) in *HOXD12* and *HOXD13* were found to be associated with idiopathic clubfoot.^[@CR21]^ A *HOXD10* missense mutation segregated with a related disorder, called congenital vertical talus, in a British family,^[@CR22]^ and that same mutation was also described as segregating in a family of Italian descent with both clubfoot and Charcot-Marie-Tooth Disease.^[@CR23]^ Four SNPs in the HOXA cluster showed altered transmission in a case-control study, but gene-gene interactions were identified between *HOXA*and *HOXD* variants and previously associate SNPs in mitochondrial-mediated apoptotic genes.^[@CR24]^ However, a functional analysis of a SNP in *HOXA9*created allele-specific nuclear protein interactions and caused higher promoter activity, suggesting that *HOXA9* promoter variants alter expression, thus playing a functional role in the underlying mechanisms of isolated clubfoot.^[@CR25]^ Most recently, *HOXC* microdeletions were shown to overlap a noncoding region upstream of *HOXC13*. The authors found a missense SNP in *HOXC11* to segregate in a family with isolated clubfoot, and a missense SNP in *HOXC12* was enriched in clubfoot patients.^[@CR26]^

Muscle contractile genes {#Sec2.3}
------------------------

There is conflicting evidence of the role of muscle contractile genes in isolated clubfoot. While they are good candidate genes due to their expression either embryonically or perinatally, which is the period during which isolated clubfoot develops, and are part of Type II muscle, which is known to be decreased in clubfoot patients,^[@CR27]^ no groups have found any evidence of contractile gene association with isolated clubfoot.^[@CR27],[@CR28]^ This suggests a different pathophysiology than the syndromic form of clubfoot so often seen in DA syndromes, for which muscle contractile genes have proved of importance. However, a study performed two years later found an association with two SNPs in *TNNC2* and isolated clubfoot, as well as SNPs in *TPM1* and *TPM2*.^[@CR29]^ Functional analyses of SNPs in *TPM1*and *TPM2*have been shown to cause allele-specific higher promoter activity, suggesting a functional role for these gene promoters in isolated clubfoot.^[@CR25]^

Environmental *in utero* causes {#Sec2.4}
-------------------------------

Smoking during pregnancy has been associated with birth defects including clubfoot.^[@CR2],[@CR30]^ *N*-acetylation genes *NAT1* and *NAT2* modulate the biotransformation of exogenous substances such as tobacco smoke, and one study found that there were significantly more slow *NAT2* acetylators among clubfoot cases.^[@CR31]^ A SNP in *CYP1A1*, a nicotine metabolism gene, was also weakly associated with isolated clubfoot.^[@CR30]^ Similarly, low folate levels during pregnancy can lead to congenital malformations. An interaction between genotype at a missense SNP in the methylenetetrahydrofolate reductase gene and maternal folic acid usage was found, leading to decreasing relative risk for isolated clubfoot in an allele dosage type manner.^[@CR32]^

Apoptotic genes {#Sec2.5}
---------------

Apoptotic genes involved in the cell death cascade that aid in shaping the developing limb (*CASP8, CASP10* and *CFLAR*) had been previously associated with microsatellite markers spanning a deletion of chromosomal region 2q31-33 linked with isolated clubfoot.^[@CR33]^ However, after further genotyping of 40 SNPs in seven genes involved in apoptosis was performed no significant associations were found.^[@CR34]^

Other genes {#Sec2.6}
-----------

Filamin B (*FLNB*) is an actin-binding protein that crosslinks actin cytoskeleton filaments into a dynamic structure.^[@CR35]^ Three novel missense mutations in *FLNB*have been associated with isolated clubfoot.^[@CR36]^ In the only genome-wide association study for clubfoot to date, a SNP on chromosome 12q24.31 between *NCOR2* and *ZNF664* was associated with clubfoot in both the initial and replication datasets. Suggestive SNPs were identified near *FOXN3, SORCS1* and *MMP7*, suggesting a role for common variants in several non-candidate genes.^[@CR37]^

Genetics of syndromic clubfoot {#Sec3}
==============================

Distal Arthrogryposis {#Sec3.1}
---------------------

One of the most common syndromic causes of clubfoot is arthrogryposis. It occurs in one of 3000 to one in 5000 live births.^[@CR38]^ However, given how many specific subtypes there are, each is relatively rare. This term is used to describe multiple congenital contractures. Arthrogryposis is not a diagnosis in itself, but rather a symptom, and implies contractures in multiple regions of the body. It is present in over 400 specific conditions.^[@CR39]^ *In utero*, arthrogryposis is often associated with decreased foetal movement, which results in connective tissue abnormalities and muscle atrophy, among other features. DA is a group of syndromes with predominantly distal contractures of the hand and foot. DA in many cases has an underlying genetic cause ([Table 1](#T1){ref-type="table"}^[@CR40]^). However, unlike isolated clubfoot, DA has most consistently been shown to be caused by variants in sarcomeric muscle proteins responsible for muscle contraction, many of which are only expressed early in development.^[@CR41]-[@CR44]^

###### 

Distal arthrogryposes (DA) and associated genes adapted from Hall et al (2017)(40)

  Type   Condition/syndrome name                                   Known genes
  ------ --------------------------------------------------------- -----------------------------
  DA1    Classic DA                                                *TNNI2, TPM2, MYBPC1, MYH3*
  DA2A   Freeman-Sheldon Syndrome                                  *MYH3*
  DA2B   Sheldon-Hall Syndrome                                     *TNNI2, TPM2, MYBPC1, MYH3*
  DA3    Gordon Syndrome                                           *PIEZO2*
  DA5    DA with ophthalmoplegia, psosis and retinal involvement   *PIEZO2, ECEL1*
  DA7    Trismus-pseudocamptodactyly syndrome                      *MYH8*
  DA8    Autosomal dominant multiple pterygium syndrome            *MYH3*
  DA9    Congenital contractural arachnodactyly/Beals syndrome     *FBN2*

While distal arthrogryposis type 3 (DA3) and distal arthrogryposis type 5 (DA5) as well as the phenotypically similar Marden-Walker Syndrome are caused by autosomal dominant mutations in *PIEZO2*,^[@CR45],[@CR46]^ a separate phenotype in individuals lacking *PIEZO2* causes muscular atrophy with spinal deformities and DA as a symptom.^[@CR47]^ This gene encodes an ion channel critical for proprioception. *FBN2*is a component of connective tissue and elastic fibre assembly, mutations in which cause distal arthrogryposis type 9 (DA9).

Many syndromes besides the distal arthrogryposes also have clubfoot as a symptom and are known to have a genetic basis ([Table 2](#T2){ref-type="table"}). Some, though not all of these genes, fall into known categories that can easily be understood in the context of the pathogenesis of clubfoot.

###### 

Syndromic clubfoot causes and associated genes

  Condition/syndrome name                                                             Known genes
  ----------------------------------------------------------------------------------- ---------------------------------------------------------
  Autosomal Dominant Larsen Syndrome, Recessive spondylocarpotarsal syndrome          *FLNB (35, 69, 70)*
  Barth Syndrome                                                                      *TAZ (71)*
  Bruck Syndrome                                                                      *PLOD2, FKBP10 (72)*
  Carey-Fineman-Ziter Syndrome                                                        *MYMK (73)*
  Catel-Manzke Syndrome                                                               *TGDS (67)*
  Charcot-Marie-Tooth Disease Type 4D                                                 *NDRG1 (74)*
  Diastrophic dysplasia                                                               *SLC26A2 (56)*
  Ehlers-Danlos Syndrome, Musculocontractural type 1                                  *CHST14 (64, 75)*
  Ehlers-Danlos Syndrome, Musculocontractural type 2                                  *DSE (63)*
  Ehlers-Danlos Syndrome, vascular type                                               *COL3A1 (76)*
  Epileptic Encephalopathy                                                            *AARS (58)*
  Joubert Syndrome                                                                    *ATXN10, TCTN2 (77)*
  Loeys-Dietz Syndrome                                                                *TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3 (48, 51)*
  Marfan Syndrome                                                                     *FBN1, TGFBR, TGFBR1, TGFBR2, SMAD3, TGFB2, SKI (48)*
  Mobius Syndrome                                                                     *PLXND1, REV3L (78, 79)*
  Multiple Epiphyseal Dysplasia                                                       *COL9A1, COL9A2, COL9A3, COMP, MATN3, SLC26A2 (54, 55)*
  Multiple Synostosis Syndrome                                                        *GDF5 (52)*
  Peroxisome biogenesis disorder 7A                                                   *PEX26 (60)*
  Recessive axonal Charcot-Marie-Tooth Disease                                        *LMNA, GDAP1 (80)*
  Recessive Larsen Syndrome, Humero-Spinal Dysostosis, Spondyloepiphyseal dysplasia   *CHST3 (61, 65)*
  Richieri-Costa -- Pereira Syndrome                                                  *EIF4A3 (81)*
  Santos Syndrome                                                                     *WNT7A (82)*
  Saul-Wilson Syndrome                                                                *COG4 (66)*
  Schpritzen-Goldberg Syndrome                                                        *SKI (50)*
  TARP Syndrome                                                                       *RBM20 (83)*
  Van Maldergem Syndrome 2                                                            *DCHS1, FAT4 (84)*

Transforming growth factor beta (TGF-β) signalling {#Sec3.2}
--------------------------------------------------

TGF-β signalling regulates cellular processes including proliferation, apoptosis, differentiation and extracellular matrix formation and remodelling. It is also involved in skeletal, vascular and hematopoietic homeostasis.^[@CR48],[@CR49]^ Genes in this pathway including *TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3* and *SKI* have been implicated in hereditary connective tissue disorders including Marfan Syndrome, Loeys-Dietz Syndrome and Schprintzen-Goldberg Syndrome.^[@CR48],[@CR50],[@CR51]^ *GDF5*, a bone morphogenetic protein and part of the TFG-β family that was previously referred to as cartilage derived morphogenetic protein 1 (CDMP-1), is a growth factor that is expressed during several critical periods of skeletal development. Mutations in this gene are associated with multiple syndromes including synostosis syndrome and brachydactyly type C.^[@CR52]^

Extracellular matrix (ECM) {#Sec3.3}
--------------------------

The ECM provides structural support for organs, tissues and cell membranes. They also play a role in cell differentiation, proliferation survival and migration. Extracellular matrix binding helps to regulate TGF-β signalling.^[@CR53]^ Mutations in genes encoding ECM proteins *COL9A1, COL9A2, COL9A3, COMP* and *MATN3* as well as the transmembrane glycoprotein involved in matrix organization, *SLC26A2*, have been associated with multiple epiphyseal dysplasia.^[@CR54],[@CR55]^ *SLC26A2* mutations have also been associated with distrophic dysplasia, a non-lethal form of de la Chapelle dysplasia.^[@CR56]^ Mutations in the ECM protein encoded by *FBN1* are known to cause Marfan Syndrome.^[@CR48],[@CR57]^ *COL3A1*mutations cause a vascular type of Ehlers-Danlos syndrome.^[@CR58]^

Peroxisomal defects {#Sec3.4}
-------------------

Peroxisomes are organelles that play an essential role in several cellular and metabolic pathways. *GDAP1* is involved in the fission of peroxisomes, and patients with *GDAP1* mutations display a Charcot-Marie-Tooth phenotype where mitochondria and peroxisomes are elongated in cells. Mutations in peroxisomal biogenesis factors (PEX) genes including *PEX26* can disrupt import of peroxisomal matrix proteins.^[@CR59]^ Mutations in *PEX26* are a known cause of peroxisome biogenesis disorder.^[@CR60]^ Both of these disease phenotype sequelae include clubfoot.

Proteoglycans {#Sec3.5}
-------------

Proteoglycans are a component of connective tissues that consist of glycosaminoglycan (GAG) polymer chains attached to core proteins. GAG sugar composition (dermatan, chondroitin, heparin) helps determine the biological roles and tissue distributions of the macromolecules produced.^[@CR61]^ Dermantan sulfate proteoglycans are components of diverse connective tissues, defects in which can result in abnormal collagen fibril assembly. It is also known to interact with heparin cofactor II and can modulate thrombus formation.^[@CR62]^ *CHST14*and *DSE*encode two enzymes necessary for dermatan sulfate biosynthesis. Mutations in these genes cause the musculocontractural types of Ehlers-Danlos syndrome, both of which present with clubfoot.^[@CR63],[@CR64]^ *CHST3* encodes an enzyme that catalyzes sulfation of chondroitin containing proteoglycan, which is a necessary part of connective tissues.^[@CR65]^ Mutations in *CHST3*have been associated with skeletal dysplasias that can present with clubfoot, including humero-spinal dysostosis and spondyloepiphyseal dysplasia, as well as recessive Larsen syndrome.^[@CR61],[@CR65]^ Initiation and polymerization of GAG occurs in the Golgi apparatus. A mutation in *COG4*has been found to disrupt this process, resulting in a rare cause of dwarfism that presents with multiple limb malformations including clubfoot, known as Saul-Wilson syndrome.^[@CR66]^ Lastly, *TGDS*, a member of the short-chain reductase family, is also suspected to be involved in proteoglycan synthesis or sulfation. Mutations in this gene cause Catel-Manzke syndrome, which can present with clubfoot.^[@CR67],[@CR68]^

Discussion {#Sec4}
==========

Here we have shown that a variety of pathways and categories of genes are involved in both isolated and syndromic clubfoot. To our knowledge, this is the first time that genes involved in syndromic clubfoot have been categorized in an attempt to better understand the biology of this deformity. While some of the categories were known or expected, such as TGF-β signalling and extracellular matrix components, others including peroxisomal defects and proteoglycans, were novel.

We posit that examination of rare variants in syndromic clubfoot genes could yield associations with isolated clubfoot. It is promising that *FLNB*has already been associated with both isolated clubfoot and with autosomal dominant Larsen syndrome. We believe that by elucidating new genes and pathways that underlie clubfoot, we will both be able to increase the explained amount of heritability of isolated clubfoot, as well as increase our overall understanding of the disease process.
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